Association of urokinase gene 3′-UTR T/C polymorphism with bladder cancer

Urologia Internationalis

Volumn 77, Issue 1, 2006, Pages 81-84

  Manchanda, Parmeet Kaur ^a   Bid, Hemant Kumar ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bladder cancer; Polymerase chain reaction; Single nucleotide polymorphism; Urokinase

Indexed keywords

CYSTEINE; MUTANT PROTEIN; THREONINE; UROKINASE;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BLADDER; BLADDER CARCINOMA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; TRANSITIONAL CELL CARCINOMA;

3' UNTRANSLATED REGIONS; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 33745818936     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092940     Document Type: Article

References (20)

1. Parkin DM: International variation. Oncogene 2004;23:6329-6340.
2. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ: Genotypes of TNF-α, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 2005;65:70-75.
3. Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22.
4. Seddighzadeh M, Steineck G, Larsson P, Wijkstrom H, Norming U, Onelov E, Linder S: Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms. Int J Cancer 2002;99:721-726.
5. Testa JE, Quigley JP: The role of plasminogen activator in aggressive tumor behavior. Cancer Metastasis Rev 1990;9:353-367.
6. Duffy MJ, Duggan C: The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 2004;37:541-548.
7. Tripputi P, Blasi F, Verde P, Cannizzaro LA, Emanuel BS, Croce CM: Human urokinase gene is located on the long arm of chromosome 10. Proc Natl Acad Sci USA 1985;82:4448-4452.
8. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
9. Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC: Urokinase gene 3′-UTR T/C polymorphism is associated with urolithiasis. Urology 2002;59:458-461.
10. Przybylowska K, Smolarczyk K, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B: A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer. J Exp Clin Cancer Res 2001;20:569-572.
11. Tsai MH, Chen WC, Chen HY, Tsai FJ: Urokinase gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 2004;18:276-279.
12. Wu HC, Chang CH, Chen WC, Chen HY, Tsai FJ: Urokinase gene 3′-UTR T/C polymorphism is not associated with bladder cancer. Genet Mol Biol 2004;27:15-16.
13. Gaylis FD, Keer HN, Wilson MJ, Kwaan HC, Sinha AA, Kozlowski JM: Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype. J Urol 1989;142:193-198.
14. Look MP, Foekens JA: Clinical relevance of the urokinase plasminogen activator system in breast cancer. APMIS 1999;107:150-159.
15. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991;138:1059-1067.
16. Skriver L, Larsson LI, Kielberg V, Nielsen LS, Andresen PB, Kristensen P, Dano K: Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol 1984;99:752-757.
17. Yasuda T, Sakata Y, Kitamura K, Morita M, Ishida T: Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck. Head Neck 1997;19:611-616.
18. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD: Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 2005;48:339-344.
19. Stern MC, Umbach DM, Lunn RM, Taylor JA: DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:939-943.
20. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, Kakinuma H, Sato K, Nakamura A, Ogawa O, Kato T: Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 2002;23:257-264.